Covid-19 Alert: if you have cold or flu-like symptoms (fever, cough, difficulty breathing, body aches, or chills, headache, sore throat, or loss of taste or smell), you must call us at 515.282.2921 before coming into Mission Cancer + Blood, even if you have an appointment. Tell us about your symptoms before coming in – Thank you!

POST NEOADJUVANT S1418

Study #S1418

A Randomized Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with ≥ 1cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy.

Back To Clinical Trials